跳至主要内容
临床试验/CTRI/2022/02/040005
CTRI/2022/02/040005尚未招募2 期

Preclinical and clinical evaluation of Siddha drug Veppampoo Mathirai in uraththa pitha vaatham - Systemic Hypertension

Self0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
Self

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed systemic Hypertension patients having blood pressure value systolic 140-179mmHg and diastolic 90-109mmHg, willing to give written consent to participate in the study

排除标准

  • Blood pressure value having systolic greater or equal to 180mmHg and diastolic greater or equal to 110mmHg, Secondary hypertension, Diabetes mellitus, cardiovascular disease/ hepatic disease, asthmatic and copd patients, pregnant women and lactating mothers, patients who are on steroids, oral contraceptive pills, oestrogen replacement therapy.participants will be excluded clinically or based on available medical reports.

研究者

发起方
Self

相似试验

Siddha drug veppampoo Mathirai for Blood pressure | 临床试验